BCC
AMRX icon

Bridge City Capital’s Amneal Pharmaceuticals AMRX Stock Holding History

Bridge City Capital’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-56,025
Closed -$794K – 92
2019
Q1 		$794K Sell
56,025
-533
-0.9% -$7.04K 0.46% 86
2018
Q4 		$765K Buy
56,558
+6,124
+12% +$110K 0.5% 85
2018
Q3 		$1.12M Sell
50,434
-2,132
-4% -$44.9K 0.7% 73
2018
Q2 		$863K Buy
+52,566
New +$923K 0.55% 88

Other funds holding AMRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bridge City Capital's AMRX Position: Q2 2019 in Review

Bridge City Capital sold out of Amneal Pharmaceuticals (AMRX) in Q2 2019, closing a stake of 56,025 shares — an estimated $794K sold.

Bridge City Capital first reported a position in AMRX in Q2 2018 and held it in 4 quarters. The position peaked at $1.12M in Q3 2018. 129 funds tracked by Wall St. Rank hold AMRX as of Q2 2019.

  • Bridge City Capital reported no remaining Amneal Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Bridge City Capital sold 56,025 Amneal Pharmaceuticals shares in Q2 2019, an estimated $794K.
  • Bridge City Capital first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 4 quarters.
  • Bridge City Capital's Amneal Pharmaceuticals position peaked at $1.12M in Q3 2018.
  • 129 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2019.

Based on Bridge City Capital's 13F filing for Q2 2019, filed 25 Jul 2019.